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INTRODUCTION
The destruction of erythrocytes coated with IgG antibody by reticuloendothelial cells in vitro (1, 2) and in vivo (3, 4) is mediated by receptors for the Fe portion of IgG. Variations in the quantity (2, 5) , configuration (5) , and subclass (6, 7) ofthe antibody coating ofthe erythrocytes have been shown to influence profoundly the rate of leukocyte-mediated erythrocyte destruietion. In addition, recent studies suggest that variations in reticuloendothelial function also influence Fc receptormediated immune clearance. Patients with systemic lupus erythematosus (8) , nephritis (9) , vasculitis (9) , or Sj6gren's syndrome (10) sequester and destroy erythrocytes coated with IgG antibody in their spleen more slowly than normal volunteers. This reduction in Fc receptor function may be a primary disorder contributing to tissuie damage in these (liseases (8, 10) or may be duie to interference with Fc receptor function by immune complexes containinig IgG (9, 11) . In the following studies in vitro, we demonstrate that complexes containing IgG can reversibly reduce Fc receptor function of human monocytes, and that this process proceeds by an energy-dependent step(s) to the irreversible loss ofreceptor function. This process of receptor degradation may be of importance in the pathophysiology of a variety of disease states. serum (FCS), and penicillin and streptomycin solution (P + S) (10,000 U/ml and 10,000 Zg/ml, respectively) were obtained from Gibco Laboratories, Grand Island Biological Co., Grand Island Preparation of anti-IgG. Anti-IgG was prepared as described previously (14) . A purified IgG fraction of this antiserum was prepared by passage of serum dialyzed against a 0.05-M buffer through a 2.0 x 20.0-cm column of DEAE Affigel Blue (Bio-Rad Laboratories, Richmond, Calif.) using the method recommended by the manufacturer. Fab2 fragments were prepared by incubation of IgG with 1% by weight of pepsin in sodium acetate buffer at pH 4.4 for 36 h. Fab2 fragments were then isolated by passage through a 100 x 2-cm Sephadex G-150 column (15) Preparation of EC43 was carried out using methods previously described (16) . Human O+ erythrocytes were incubated with an IgM cold agglutinin antibody and fresh human serum for 10 min at 4°C and 10 min at 37°C, and then were washed thoroughly to remove remaining antibody and unbound complement components. Erythrocytes prepared in this fashion have been shown in the past to be coated with C3 and C4.
Preparation of human serum. 50 ml of blood were drawn sterilely, cooled to 40C, and centrifuged at 12,000 g for 1 min.
The plasma then was removed, incubated at 37°C for 30 min, and serum was then separated mechanically from the clot.
Preparation of adherent monocytes. The mixture of erythrocytes, platelets, and leukocytes remaining after the removal of plasma above was mixed rapidly with 20 cm3 of RPMI 1640 containing 10 U/ml of sodium heparin. The cell suspension was then washed three times with RPMI 1640 and layered over 20 ml of Ficoll-Hypaque (17) (Pharmacia Fine Chemicals). The tube was centrifuged at 500 g for 10 min and 1,000 g for 20 min. The mixed mononuclear cells obtained from the interface were washed three times with RPMI and were resuspended in RPMI 1640 plus 20% FCS at a concentration of 5-10 x 106 leukocytes/ml. 50-,ul portions of this suspension were added to wells in sterile, 96-well, flat bottom microtiter plates (Falcon Labware, Div., Becton, Dickinson & Co., Oxnard, Calif.), and incubated at 37°C for 30 min. Each well was then washed six times with PBS to remove nonadherent lymphocytes, erythrocytes, and platelets. Greater than 90% of adherent leukocytes were monocytes, as judged by morphologic appearance and the capacity to ingest latex beads. Monocyte monolayers to be maintained in vitro for <24 h were overlaid with RPMI 1640 with 10% FCS and P + S, but for more prolonged incubations monocytes were incubated in N-T medium with 20% autologous human serum and P + S in a modification ofthe method ofJohnson et al. (18) at 37°C in a moisturized 5% CO2 incubator.
Incubation of monocytes with IgGi. Unless otherwise stated, incubations were performed by suspending mixed mononuclear cells (5 x 106/ml) in medium containing IgGl in 12 x 75-mm plastic tubes at 37°C. After incubation, the cells were washed four times with PBS, resuspended in RPMI 1640 plus 20% FCS, and monocytes were allowed to adhere to microtiter plates, as described above, before assessment of Fc receptor (or other) function.
Incubation of monocytes with anti-IgG. Unless otherwise noted, incubation was performed by adding 50 pl ofantiIgG diluted 1:250 in RPMI 1640 to wells containing adherent, purified monocytes prepared as described above. After incubation, each well was washed a total of eight times with PBS to remove unbound anti-IgG before the assessment of Fc receptor function.
Trypsin treatment of adherent monocytes. Wells containing adherent monocytes were washed four times with PBS to remove unbound IgGl or other protein, and 100 ,ul of RPMI 1640 containing trypsin (1 mg/ml) was added to each well. The adherent cells were incubated at 37°C for 30 min and were washed again with PBS four times.
Assessment of Fc receptorfunction. Adherent monocytes with or without prior treatment with trypsin were overlaid with 50 ,ul of a 0.4% suspension of EA in RPMI 1640 with 10% FCS and erythrocytes were permitted to sediment onto the adherent monocytes at 37°C. After incubation for 60 min, 50 pul of 0.5% glutaraldehyde in saline was added to each well for 10 min at room temperature and then each well was washed throughly with PBS, dried, and stained with Giemsa stain. Receptor activity was assessed in each well of the inverted microtiter plate at x200. Monocytes with three or more adherent erythrocytes or with one or more ingested, or partially ingested, erythrocytes were considered to possess Fc receptor function. The percentage of monocytes with Fc receptor function was quantitated in each of three microtiter wells by scoring at least 100 cells for evidence of interaction with EA. The mean and standard deviation was calculated for each set of samples. Less than 1% ofmonocytes interacted with human erythrocytes not coated with IgG antibody.
Complement receptor function was measured by adding 50 pl of a 0.4% suspension of EC43 to microtiter wells containing adherent monocytes that had been washed as described above. Cells to be evaluated for complement receptor function were not treated with trypsin which is known to destroy complement receptor function (19 (Table  II) . Pretreatment of monocytes with trypsin (to uncover receptor sites blocked with cytophilic IgG) before the addition of aggregates did not prevent either the loss of receptor function or the restoration of function produced by a second incubation with trypsin after contact with purified aggregates (data not shown).
Monocytes incubated with a more dilute solution of purified aggregates (0.6 mg/ml) lost Fc receptor function more slowly, but after 18 h receptor loss was nearly complete and was not reversed by trypsin (Table II) . A 10-mg/ml solution of heat-aggregated IgG (which contained -30% aggregated IgGI and 70% monomeric IgGl) reduced Fc receptor function minimally even after incubation for 18 h; however, if after incubation with this solution for 1 h monocytes were washed and incubated in medium alone, Fc receptor function was lost over the following 17-h period (Table III) . During the first 12 h of incubation after washing, this loss of Fc receptor function could be partially reversed by trypsin but after longer intervals, loss of function could not be reversed (Fig. 1) . The failure of crude heat-aggregated IgGI to reduce Fc receptor function appears to be due (Fig. 4 0) although nearly all monocytes still possessed Fc receptors detectable after incubation with EApapain (Fig. 4, 0) . If Fc receptor function was depleted by treatment with anti-IgG, it was restored very slowly in vitro and did not return to the level of undepleted monocytes similarly cultured even after 4 d (Fig. 5, 0) , but significant restoration of Fc receptor function could be detected using EApapain within 6-12 h of incubation (Fig. 5, 0) . This restoration was inhibited by the addition of cycloheximide (2 ,ug/ml (Fig. 6,  0) or by the deletion of serum from the incubation medium (Fig. 6, A (25) . Our findings support the hypothesis (20, 21, 23 ) that modulation results from the formation of stable complexes between adsorbed IgG and Fc receptors that migrate to the site of contact with IgG from other parts of the cell surface (Fig. 7A) . Because receptor loss is reversible, it is unlikely that receptor denaturation or internalization is important in the loss offunction as has been suggested by others (22 monomeric IgG (24) with a much slower rate of (issociation (26), we presume that the rapid loss of Fc receptor function following incubation ofmonocytes with concentrated solutions of purified aggregates results from the saturation of available receptors with IgGI aggregates. We attribute the return of function after trypsin treatment to the degradation of IgGI aggregates still bound to the receptors on the cell membrane. Since function was restored by trypsin, even after incubation with concentrated aggregates for 18 h, IgG-Fc receptor complexes apparently can remain on the membrane surface without ingestion, shedding, or denaturation for prolonged periods.
When monocytes were incuibated with lower concentrations ofpurified aggregates or with heat-treated IgGl and then washed to remove contaminating monomeric IgGI, Fc receptor function gradually was lost over a 12-18-h period and could not be restored with trypsin. We propose that delayed loss of Fc receptor function occurred because smaller amounts of multivalent aggregates bound to the monocyte membrane initially by only a few of the total Fc fragments available could subsequently bind additional receptors (Fig. 7B) . The eventual irreversibility of receptor loss in this instance suggests that these complexes are ingested by monocytes as are other receptor-ligand complexes (27) . Alternatively, receptors may be denatured or shed, although there is no data as yet to support these mechanisms.
It is unclear why irreversible receptor loss did not occur when cells were incubated with very high concentrations of IgGl aggregates but it is possible that high concentrations of membrane-bound complex "overload" the cell's capacity to organize the process of ingestion or, alternatively, for the binding of anti-IgG to the surface of monocytes, receptor loss mediated by anti-IgG appears to proceed by the same mechanism as described above (Fig. 7C) , since the loss of Fc receptor activity is dependent upon membrane binding of IgG-anti-IgG with an intact Fc fragment. The ability to deplete selectively Fc receptor function in vitro permits the quantitative study of the rate of regrowth of receptors in vitro. Such regrowth has been evaluated previously, but the methods used for depleting Fc receptor function have had substantial limitations (21, 29) . The methods of depletion described here are simple, specific, and without major morphologic consequences to the treated cells and, thus, appear better suited to the study of membrane receptor dynamics.
The perceived level of Fc receptor function of monocytes incubated in vitro in these experiments varied depending upon the characteristics of the antibodycoated erythrocytes used to detect receptor function. Fc receptor function detected with erythrocytes coated with IgG anti-D antibody diminished substantially during incubation in vitro, and receptor regrowth after depletion was incomplete after incubation in vitro for 4 d. In contrast, Fc receptor function detected using erythrocytes treated with papain before antibody sensitization was present in >90% of monocytes after 2 d of incubation in vitro. After depletion with anti-IgG, function was largely restored within 12-24 h, a rate of recovery close to that reported previously (21, 29 
